A study demonstrated that pre-transplant measurable residual disease (MRD) status is a strong prognostic factor for overall ...

Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...

Investors might want to bet on Allogene Therapeutics (ALLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Oppenheimer has recently resumed Allogene Therapeutics Inc (ALLO) stock to Outperform rating, as announced on August 8, 2024, according to Finviz. Earlier, on May 31, 2024, Piper Sandler had initiated ...

UAE-based Allo.xyz, a platform for real-world asset (RWA) tokenization and lending, has secured a $100 million Bitcoin-backed ...

Allo.xyz, a platform specializing in real-world asset (RWA) tokenization and lending, has secured a landmark $100 million ...

Addressing the $900 trillion real-world asset opportunity, Allo continues to pioneer tokenization solutions that seamlessly ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

ALLO Fiber has announced construction will soon begin this spring on a network build in the city of Boulder, Colorado.

ALLO Fiber is pleased to announce its fiber broadband network build of the City of Boulder, CO. ALLO anticipates construction to begin in the spring of 2025 in city rights-of-way and easements. This ...

Allo Communications LLC, a Lincoln, Nebraska-based telecommunications company, plans to build a fiber-optic broadband network ...